Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Journal of the Pediatric Infectious Diseases Society
This is a pilot feasibility and instrument validation study with a very small sample (n=8) testing survey clarity and comprehension, not a clinical or implementation outcome.
A policy brief presenting expert recommendations for managing infections in cancer patients amid antimicrobial resistance in sub-Saharan Africa, informed by institutional microbiological data but not a primary research study.
Rigorous multicenter randomized noninferiority trial with adequate sample size and clear primary endpoint result showing equivalence between strategies, directly addressing a clinically relevant question in pediatric cancer care.
Retrospective single-centre analysis identifying associations between chemotherapy-induced parameters and PARP inhibitor toxicity, but lacks prospective validation, external cohort confirmation, and actionable clinical thresholds for practice change.
Single-center prospective observational study with modest sample size describing incidence and risk factors for healthcare-associated infections; identifies neoadjuvant radiotherapy as an independent risk factor but lacks comparator arm and external validation.